๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Colorectal Neoplasms
Clinical trial register · China

Colorectal Neoplasms Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 9 Beijing 7 Hangzhou 5 Harbin 4 Chengdu 3
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou9 Beijing7 Hangzhou5 Harbin4 Chengdu3
All 30 locations
Target enrolment
to

Colorectal Neoplasms trials in China

23 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Effectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized Trial
NCT07307547Colorectal Neoplasms, Colonic Polyp, Adenoma, Colorectal Cancer
Zhejiang University
Not applicable
3,300
Hangzhou
2026-09
Not yet open
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
NCT07535632Colorectal Neoplasms
Shanghai Zhongshan Hospital
Phase 2
58
Shanghai
2026-06-01
Recruiting
Health Behavior Change in High-Risk Colorectal Cancer Individuals
NCT07262840Health Behavior, Colorectal Neoplasms, Primary Prevention/Methods
China Medical University, China
Not applicable
80
Shenyang
2025-11-10
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT07213791Ovarian Neoplasms, Breast Neoplasms, Pancreatic Intraductal Neoplasms, Colorectal Neoplasms
Eli Lilly and Company
Phase 1
241
Shanghai
2025-10-22
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT07114601Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms
Eli Lilly and Company
Phase 1
421
Beijing, Tianjin
2025-08-06
Not yet open
Efficacy and Safety of Robot-assisted Endoscopic Submucosal Dissection for Colorectal Neoplasm
NCT06973083Robot Surgery, Endoscopic Submucosal Dissection (ESD), Colorectal Neoplasms
Shandong University
Not applicable
104
Jinan
2025-06-01
Not yet open
Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis
NCT07007728Colorectal Neoplasms, Secondary Malignant Neoplasm of Liver
Peking University Cancer Hospital & Institute
Phase 2
54
Beijing
2025-06-01
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT06750094Colorectal Neoplasms
Janssen Research & Development, LLC
Phase 3
700
Beijing, Changchun, Changsha, Chengdu, Ganzhou, Guangzhou, Hangzhou, Harbin
2024-12-12
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
NCT06131840Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
914
Guangzhou, Jinan, Shanghai
2023-11-20
Not yet open
Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer
NCT06079242Colorectal Neoplasms
GrandPharma (China) Co., Ltd.
Observational
200
Hangzhou
2023-10-15
Not yet open
Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
NCT05730595Colorectal Neoplasms, Fluorescence, Lymph Node Excision
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
550
Hefei, Beijing, Chengdu, Fuzhou, Guangzhou, Shijiazhuang, Haerbin, Nanjing
2023-09-01
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
AstraZeneca
Phase 1
167
Beijing, Chongqing, Guangzhou, Wuhan
2022-12-21
Recruiting
A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers
NCT05592886Colorectal Neoplasms, Colorectal Adenoma, Colorectal Cancer, Advanced Adenoma
Chinese University of Hong Kong
Not applicable
649
Hohhot
2022-12-15
Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Fuzhou, Lanzhou, Guangzhou, Meizhou, Haikou, Chengde, Tangshan, Harbin
2022-10-24
Active, closed
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
NCT05239741Colorectal Neoplasms
Merck Sharp & Dohme LLC
Phase 3
100
Beijing, Tianjin, Chongqing, Fuzhou, Guangzhou, Shantou, Nanning, Harbin
2022-04-02
Recruiting
Early Detection of Advanced Adenomas and Colorectal Cancer
NCT06342440Colorectal Cancer, Colorectal Neoplasms, Colorectal Polyp, Colorectal Adenocarcinoma
City of Hope Medical Center
Observational
2,000
Dalian
2020-03-15
Not yet open
The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer
NCT03923335Colorectal Neoplasms
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
287
Guangzhou
2019-04-30
Recruiting
Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation
NCT07830576Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms
Anhui Provincial Hospital
Observational
205
Hefei
2017-02-01
Recruiting
A Study of 2nd-line FOLFIRI ยฑ Bevacizumab vs. Irinotecan ยฑ Bevacizumab in mCRC
NCT03303495Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms, Gastrointestinal Neoplasms
Sun Yat-sen University
Phase 3
280
Guangzhou
2011-11-14
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/colorectal-neoplasms

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies listing the condition Colorectal Neoplasms.

How many Colorectal Neoplasms trials are recruiting in China?

13 of the 23 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 7 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Colorectal Neoplasms), 23 studies
PhaseStudiesRecruitingShare
Not applicable5221.7%
Observational5221.7%
Phase 35421.7%
Phase 14317.4%
Phase 24217.4%

Most active sponsors

Lead sponsors with the most studies (Colorectal Neoplasms)
Lead sponsorStudiesRecruiting
Eli Lilly and Company22
Janssen Research & Development, LLC22
Seagen, a wholly owned subsidiary of Pfizer22
Zhejiang University21
Anhui Provincial Hospital11
AstraZeneca10
Cancer Institute and Hospital, Chinese Academy of Medical Sciences10
China Medical University, China11
Chinese University of Hong Kong11
City of Hope Medical Center11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.